Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 1 , Pages 46-51 , March 2009

Interactions of protoporphyrin IX and its derivatives with benzodiazepine receptor

References 

  1. Bormann J. The ‘ABC’ of GABA receptors. TiPS. 2000;21:16–19
  2. Sigel E, Buhr A. The benzodiazepine binding site of GABAA receptors. TiPS. 1997;18:425–429
  3. Papadopoulos V, Baraldi M, Guliarte TR, et al. Translokator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends in Pharmacological Sciences. 2006;27:402–409
  4. Gavish M, Bachman I, Shoukrun R, et al. Enigma of the peripheral benzodiazepine receptor. The America Society for Pharmacology and Experimental Therapeutics. 1999;51:629–650
  5. Synder SH, Verma A, Trifiletti RR. The peripheral-type benzodiazepine receptor: a protein of mitochondrial outer membranes utilizing porphyrins as endogenous ligands. The FASEB Journal. 1987;1:282–288
  6. Verma A, Nye JS, Synder SH. Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. Proceedings of the National Academy of Sciences of the United States of America. 1986;84:2256–2260
  7. Wendler G, Lindemann P, Lacapere JJ, Papadopoulos V. Protoporphyrin IX binding and transport by recombinant mouse PBR. Biochemical and Biophysical Research Communications. 2003;311:847–852
  8. Taketani S, Kohno H, Furukawa T, Tokunaga R. Involvement of peripheral-type benzodiazepine receptors in the intracellular transport of heme and porphyrins. Journal of Biochemistry. 1994;117:875–880
  9. Li W, Hardvick MJ, Rosenthal D, Culty M, Papadopoulos V. Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation. Biochemical Pharmacology. 2007;73:491–503
  10. Kessel D, Antolovich M, Smith KM. The role of the peripheral benzodiazepine receptor in the apoptotic response to photodynamic therapy. Photochemistry and Photobiology. 2001;74(2):346–349
  11. Maaser K, Sutter A, Scherubl H. Mechanisms of mitochondrial apoptosis induced by peripheral benzodiazepine receptor ligands in human colorectal cancer cells. Biochemical and Biophysical Research Communications. 2005;332:646–652
  12. Azarashvili T, Grachev D, Krestinina O. The peripheral-type benzodiazepine receptor is involved in control of Ca2+-induced permeability transition pore opening in rat brain mitochondria. Cell Calcium. 2007;42:27–39
  13. Li J, Wang J, Zeng Y. Peripheral benzodiazepine receptor ligand, PK11195 induces mitochondria cytohrome c release and dissipation of mitochondria potential via induction of mitochondria permeability transition. European Journal of Pharmacology. 2007;560:117–122
  14. Morris R, Varnes ME, Kenney ME. The peripheral benzodiazepine receptor in photodynamic therapy with the phthalocyanine photosensitizer Pc 4. Photochemistry and Photobiology. 2002;75(6):652–661
  15. Han Z, Slack RS, Li W, Papadopoulos V. Expression of peripheral benzodiazepine receptor (PBR) in human tumors: relationship to breast, colorectal, and prostate tumor progression. Journal of Receptors and Signal Transduction. 2003;23:238–255
  16. Hardvick M, Fertikh D, Culty M, Li H, Vidic B, Papadopoulos V. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Research. 1999;59:831–842
  17. Veenman L, Levin E, Weisinger G. Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines. Biochemical Pharmacology. 2004;68:689–698
  18. Brancaleon L, Moseley H. Effects of photoproducts on the binding properties of protoporphyrin IX to proteins. Biophysical Chemistry. 2002;96:77–87
  19. Tian F, Johnson K, Lesar AE, et al. The pH-dependent conformational transition of beta-lactoglobulin modulates the binding of protoporphyrin IX. Biochimica et Biophysica Acta. 2006;1760:38–46
  20. Tian F, Johnson EM, Zamarripa M, Sansone S, Brancaleon L. Binding of porphyrins to tubulin heterodimers. Biomacromolecules. 2007;8:3767–3778
  21. Kubat P, Lang K, Anzenbacher P. Modulation pf porphyrin binding to serum albumin by pH. Biochimica et Biophysica Acta. 2004;1670:40–48
  22. Guo M, Zou JW, Yi PG, Shang ZC, Hu GX, Yu QS. Binding interaction of gatifloxacin with bovine serum albumin. Analytical Sciences. 2004;20:465–470
  23. Sułkowska A, Równicka J, Bojko B, Sułkowski W. Interaction of anticancer drugs with human and bovine serum albumin. Journal of Molecular Structure. 2003;651–653:133–140
  24. Jong LAA, Uges DRA, Franke JP, Bischoff R. Receptor–ligand binding assays: technologies and Applications. Journal of Chromatography B. 2005;829:1–25
  25. Epps ED, Raub TJ, Kezdy FJ. A general, wide-range spectrofluorometric method for measuring the site-specific affinities of drugs toward human serum albumin. Analytical Biochemistry. 1995;227:342–350
  26. Cohen S, Margalit R. Binding of porphyrin to human serum albumin. Biochemistry Journal. 1990;290:325–330
  27. Villamor JP, Zaton AML. Data plotting of warfarin binding to human serum albumin. Journal of Biochemical and Biophysical Methods. 2001;48:33–41

PII: S1572-1000(09)00005-2

doi: 10.1016/j.pdpdt.2009.01.004

Photodiagnosis and Photodynamic Therapy
Volume 6, Issue 1 , Pages 46-51 , March 2009

Article Tools

* Image Usage & Resolution